I graduated from the University of Mount Union in 2020 where I received my B.S. in biology with a minor in chemistry. I have been working in Dr. Shin’s lab as a Research Technician since October 2020. Our primary project has been the testing and development of metallo beta-lactamase inhibitors as combinational drug therapy for multi-drug-resistant bacteria. I will be starting the Integrated Pharmaceutical Medicine program in Fall 2021, where I plan to continue researching mechanisms of antimicrobial resistance to identify targets for therapeutic intervention.

I am a P3 Pharmacy student at Northeast Ohio Medical University. My personal long-term goal is to extend my knowledge and exposure in research in order to fulfill my long-term goal of practicing research as a pharmacist. I joined Dr. Shin’s research lab in April 2021, where I work on proteomics and computer-aided drug design (CADD) to discover, develop, and analyze drugs and similar biological active molecules. Once a compound is in hand from using in-silico studies, the compound will be validated using in-vitro and in-vivo assays. 

I received my BS in biomedical sciences at Xavier University and my MA in bioethics and medical humanities at Case Western Reserve University. I began exploring research while in college and studied multi-drug-resistant organisms such as Elizabethkingia anopheles, as well as Tebipenem and its interaction with beta-lactamases. I plan to further my knowledge regarding drug resistance as a student fellow in the Shin lab and hope to learn more about drug research and design. 

I am a Ph.D. student in microbiology at Kyungpook National University, specializing in multidrug-resistant bacteria, a critical threat to global public health. My research focuses on discovering anti-virulence targets and agents, studying the epidemiology of antimicrobial-resistant pathogens, and exploring the role of membrane vesicles in their pathogenicity. As an exchange visitor at Northeast Ohio Medical University, I am participating in Dr. Shin’s lab to gain expertise in computer-aided drug design and advanced experimental techniques.

I am interested in the discovery of anti-tau compounds for Alzheimer's Disease. I have previously studied this in prior classes and it really caught my attention. I am hoping to continue being involved in the development of the flavonoid analogs for treating  AD. I enjoyed doing the behavioral studies and also like doing the IP injections of the compounds. 

After earning a B.S. and M.S. in Chemistry at Kent State University, Dr. Bogdan Benin moved to Zurich, Switzerland where he earned his Ph.D. from ETH Zurich in inorganic chemistry. Upon competition of his doctoral studies, Dr. Benin co-founded Lawsonex to develop and commercialize antimicrobials targeted at drug-resistance bacteria. Dr. Benin’s current research interests are centered on the discovery of new antimicrobial materials, the elucidation of their mechanisms through crystallography and computation, as well as the potential to utilize crystallography and computational tools to better understand the intersection of solid-state materials with biological systems. 

At this time, my research interests are kind of broad. I'm very curious in learning more about neurological disorders, ranging from neurodegeneration, nerve pain, and mood disorders. I'd love to learn more about drug development from start to finish, and I have a special interest in learning more about computer-aided drug design, but I also really enjoy basic science and translational research methods as well. 

Sahar enjoys experimenting and exploring different paths in the pharmaceutical industry. In Sahar’s early years of undergrad, she discovered her love for benchwork and lab work. Sahar currently works as a student fellow in Dr. Shin’s Lab, learning about computational work of binding protein structures as well as drug discovery. She plans to complete her project in Dr. Shin’s lab this summer and present her data in the near future. Sahar’s interest includes research, academia, and clinical drug trials. Sahar also enjoys admiring nature, learning more about coding, as well as being active in the community.

I am a P1 Pharmacy student at Northeast Ohio Medical University. 

▪ I am interested in drug resistance overall, and more specifically multi-drug resistant UTIs.

▪ Hope to contribute to the design and discovery of a FimH inhibitor to stop the binding of bacteria involved with UTI’s to host cells.

▪ I’d like to gain experience with various different lab techniques/methods as well at computer-aided drug design

Andrew is a current PharmD/Ph. D. student and he has a strong research interest in drug design and development. He is currently contributing a lot to the E. coli pili FimH Inhibitor research using 3D model computational analysis and screening for some biological analysis.

Payton is a current Biomedical Sciences program Ph. D. rotation student.